Craig Lipkin

607 total citations · 1 hit paper
33 papers, 401 citations indexed

About

Craig Lipkin is a scholar working on Cardiology and Cardiovascular Medicine, Epidemiology and Hematology. According to data from OpenAlex, Craig Lipkin has authored 33 papers receiving a total of 401 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Cardiology and Cardiovascular Medicine, 11 papers in Epidemiology and 8 papers in Hematology. Recurrent topics in Craig Lipkin's work include Acute Myeloid Leukemia Research (6 papers), Antiplatelet Therapy and Cardiovascular Diseases (6 papers) and Substance Abuse Treatment and Outcomes (6 papers). Craig Lipkin is often cited by papers focused on Acute Myeloid Leukemia Research (6 papers), Antiplatelet Therapy and Cardiovascular Diseases (6 papers) and Substance Abuse Treatment and Outcomes (6 papers). Craig Lipkin collaborates with scholars based in United States, Russia and China. Craig Lipkin's co-authors include Helen M. Pettinati, William D. Dundon, Zhun Cao, Kevin G. Lynch, Scott B. Robinson, Joseph R. Volpicelli, Ning Rosenthal, Frank R. Ernst, R.A. Balk and Samuel A. Bozzette and has published in prestigious journals such as SHILAP Revista de lepidopterología, Blood and Clinical Infectious Diseases.

In The Last Decade

Craig Lipkin

28 papers receiving 385 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Trends in Maternal Mortality and Severe Maternal Morbidity During Delivery-Related Hospitalizations in the United States, 2008 to 2021

2023 71 citations Dorothy A. Fink, Zhun Cao et al. JAMA Network Open profile →

Peers

Countries citing papers authored by Craig Lipkin

Since Specialization

Citations

This map shows the geographic impact of Craig Lipkin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Craig Lipkin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Craig Lipkin more than expected).

Fields of papers citing papers by Craig Lipkin

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Craig Lipkin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Craig Lipkin. The network helps show where Craig Lipkin may publish in the future.

Co-authorship network of co-authors of Craig Lipkin

This figure shows the co-authorship network connecting the top 25 collaborators of Craig Lipkin. A scholar is included among the top collaborators of Craig Lipkin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Craig Lipkin. Craig Lipkin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Outpatient revisits associated with three sentinel lymph node detection techniques for breast cancer: A propensity score weighted analysis 2025 ·SHILAP Revista de lepidopterología ·(unknown), (unknown), (unknown), Seth L. Emont, Zhun Cao, (unknown), Craig Lipkin, Sven Gunia	0
2	Associations between procedural volume, costs, and outcomes of septal reduction therapies for obstructive hypertrophic cardiomyopathy in US hospitals 2025 ·Journal of Medical Economics ·(unknown), Shanthi Krishnaswami, (unknown), Nisha Singh, Annemijn H. Jonkman, Zhun Cao, (unknown), Craig Lipkin, Andrew Wang	1
3	Trends in Maternal Mortality and Severe Maternal Morbidity During Delivery-Related Hospitalizations in the United States, 2008 to 2021 breakdown → 2023 ·JAMA Network Open ·Dorothy A. Fink, (unknown), Zhun Cao, Kelly Larson, Adrienne Smith, Craig Lipkin, (unknown), (unknown), (unknown), (unknown), (unknown), Ning Rosenthal	71
4	Association between hospital volume, clinical events, resource utilization, and costs of septal myectomy and alcohol septal ablation procedures in US patients with hypertrophic cardiomyopathy 2023 ·European Heart Journal ·(unknown), Shanthi Krishnaswami, Anand Prakash Dubey, (unknown), Annemijn H. Jonkman, Zhun Cao, Manoj Tyagi, Craig Lipkin, Andrew Wang	1
5	Ninety-day all-cause emergency room use among coronary artery bypass grafting patients associated with near-infrared fluorescence imaging: a retrospective cohort study 2023 ·Annals of Medicine and Surgery ·(unknown), (unknown), (unknown), Seth L. Emont, Zhun Cao, Craig Lipkin, (unknown), Derek D. Muehrcke	1
6	Comparison of Hospital Length of Stay and Supportive Care Utilization Between Patients Treated with CPX-351 and 7+3 for Therapy-Related Acute Myeloid Leukemia or Acute Myeloid Leukemia with Myelodysplasia-Related Changes 2022 ·SHILAP Revista de lepidopterología ·(unknown), Zhun Cao, Craig Lipkin, (unknown), Scott B. Robinson	1
7	Costs and Healthcare Resource Utilization Associated with Idarucizumab or Andexanet Alfa Oral Anticoagulant Reversal in Patients Hospitalized with Life-Threatening Bleeds 2022 ·Clinical and Applied Thrombosis/Hemostasis ·Alex C. Spyropoulos, Bríain ó Hartaigh, Zhun Cao, (unknown), Craig Lipkin, (unknown), Cheng Wang	9
8	Healthcare Resource Utilization for Oral Anticoagulant Reversal Therapies in Non-Valvular Atrial Fibrillation/Venous Thromboembolism Patients 2022 ·Cardiology Research ·Alex C. Spyropoulos, Bríain ó Hartaigh, Zhun Cao, Craig Lipkin, Scott B. Robinson, (unknown), (unknown), Cheng Wang	2
9	A Descriptive Study on Healthcare Utilization and Costs in Secondary Acute Myeloid Leukemia Patients Treated with CPX-351 Versus Those Treated with 7+3 2019 ·Blood ·(unknown), Zhun Cao, Craig Lipkin, Scott B. Robinson, (unknown)	1
10	Effect of Procalcitonin Testing on Health-care Utilization and Costs in Critically Ill Patients in the United States 2016 ·CHEST Journal ·R.A. Balk, Sameer S. Kadri, Zhun Cao, Scott B. Robinson, Craig Lipkin, Samuel A. Bozzette	40
11	Hospital Cost Associated with Veno-Occlusive Disease (VOD) in Patients with Hematopoietic Stem Cell Transplant (HSCT) 2016 ·Biology of Blood and Marrow Transplantation ·Christopher C. Dvorak, Bijan Nejadnik, Zhun Cao, Craig Lipkin, Scott B. Robinson, Kathleen F. Villa	2
12	Hospital Cost Associated with Veno-Occlusive Disease (VOD) in Patients with Hematopoietic Stem Cell Transplant (HSCT) 2015 ·Blood ·Christopher C. Dvorak, Bijan Nejadnik, Zhun Cao, Craig Lipkin, Scott B. Robinson, Kathleen F. Villa	1
13	Patient Outcomes on Day 4 of Intravenous Antibiotic Therapy in Non–Intensive Care Unit Hospitalized Adults With Community-Acquired Bacterial Pneumonia 2014 ·Infectious Diseases in Clinical Practice ·Scott B. Robinson, Frank R. Ernst, Craig Lipkin, Xingyue Huang	3
14	Real-world observations with prasugrel compared to clopidogrel in acute coronary syndrome patients treated with percutaneous coronary intervention in the United States 2014 ·Current Medical Research and Opinion ·Jay Bae, Douglas E. Faries, Frank R. Ernst, Craig Lipkin, Zhenxiang Zhao, (unknown), Hsiao D. Lieu, Mark B. Effron	20
15	PCV8 Assessment of 30-Day Rehospitalization for Acute Myocardial Infarction in Patients with Acute Coronary Syndrome Who Received Percutaneous Coronary Intervention: A Comparative Effectiveness Study of Clopidogrel and Prasugrel 2012 ·Value in Health ·Jay Bae, D Faries, (unknown), Craig Lipkin, Zhenxiang Zhao, (unknown)	0
16	Treatment Outcomes in Type A and B Alcohol Dependence 6 Months After Serotonergic Pharmacotherapy 2004 ·Alcoholism Clinical and Experimental Research ·William D. Dundon, Kevin G. Lynch, Helen M. Pettinati, Craig Lipkin	57
17	Gender Differences in Response to Sertraline Pharmacotherapy in Type A Alcohol Dependence 2004 ·American Journal on Addictions ·Helen M. Pettinati, William D. Dundon, Craig Lipkin	21
18	Cocaine Dependence Severity Predicts Outcome in Outpatient Detoxification from Cocaine and Alcohol 2004 ·American Journal on Addictions ·Kyle M. Kampman, Helen M. Pettinati, Joseph R. Volpicelli, (unknown), Craig Lipkin, Thorne Sparkman, Charles P. O’Brien	37
19	Patient Attitudes toward Treatment Predict Attendance in Clinical Pharmacotherapy Trials of Alcohol and Drug Treatment 2003 ·American Journal on Addictions ·Helen M. Pettinati, John Monterosso, Craig Lipkin, Joseph R. Volpicelli	13
20	Concurrent Cocaine Withdrawal Alters Alcohol Withdrawal Symptoms 2002 ·Journal of Addictive Diseases ·Kyle M. Kampman, Helen M. Pettinati, Joseph R. Volpicelli, (unknown), Esra Abacı Türk, (unknown), Craig Lipkin, Thorne Sparkman, Charles P. O’Brien	5

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact